[Problems in the interpretation of the percentage of glycosylated hemoglobin in patients with diabetes mellitus].
Tack
C J
CJ
Academisch Ziekenhuis, afd.Algemene Interne Geneeskunde, Nijmegen.
Lutterman
J A
JA
D000328:Adult; D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000150:complications; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000150:complications; D002851:Chromatography, High Pressure Liquid; D003922:Diabetes Mellitus, Type 1 / Q000097:blood* / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis*; D006461:Hemolysis / Q000187:drug effects; D006801:Humans; D008288:Malaria / Q000097:blood / Q000150:complications; D008297:Male; D012460:Sulfasalazine / Q000009:adverse effects
D006442:Glycated Hemoglobin; D012460:Sulfasalazine